Literature DB >> 26315369

Adenomyosis: what is new?

Levent M Senturk1,2, Metehan Imamoglu3.   

Abstract

Adenomyosis is described as the benign invasion of endometrium into the myometrium, with endometrial glands and stroma surrounded by the hypertrophic and hyperplastic myometrium. It may affect 20% of female population and most widely seen among perimenopausal and multiparous women. Its etiopathogenesis, diagnosis, clinical findings and current various treatment options will be discussed in this article.

Entities:  

Keywords:  LNG-IUS; MRI; adenomyosis; dysmenorrhea; endometrial glands; endometrial stroma; infertility; intramyometrial cysts; junctional zone; leiomyoma; menorrhagia; ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 26315369     DOI: 10.2217/whe.15.60

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  5 in total

Review 1.  Adenomyosis and Infertility-Review of Medical and Surgical Approaches.

Authors:  Maria Szubert; Edward Koziróg; Olga Olszak; Klaudia Krygier-Kurz; Jakub Kazmierczak; Jacek Wilczynski
Journal:  Int J Environ Res Public Health       Date:  2021-01-30       Impact factor: 3.390

2.  Clinicopathological characteristics and imaging findings to identify adenomyosis-related symptoms.

Authors:  Shogo Imanaka; Hiroshi Shigetomi; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Reprod Med Biol       Date:  2021-08-22

3.  Activation of the cGAS-STING signaling pathway in adenomyosis patients.

Authors:  Yun Lin; Luying Wang; Mingzhu Ye; Ke-Nan Yu; Xin Sun; Min Xue; Xinliang Deng
Journal:  Immun Inflamm Dis       Date:  2021-05-19

4.  FAK regulates epithelial‑mesenchymal transition in adenomyosis.

Authors:  Dexuan Zheng; Hua Duan; Sha Wang; Qian Xu; Lu Gan; Jinjiao Li; Qianjing Dong
Journal:  Mol Med Rep       Date:  2018-10-26       Impact factor: 2.952

5.  Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.

Authors:  Jie Lan; Yaoqiu Wu; Zexuan Wu; Yingchen Wu; Rong Yang; Ying Liu; Haiyan Lin; Xuedan Jiao; Qingxue Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.